Navigation Links
Quantitative PET imaging finds early determination of effectiveness of cancer treatment
Date:10/23/2007

RESTON, Va.With positron emission tomography (PET) imaging, seeing is believing: Evaluating a patients response to chemotherapy for non-Hodgkin lymphoma (NHL) typically involves visual interpretation of scans of cancer tumors. Researchers have found that measuring a quantitative indexone that reflects the reduction of metabolic activity after chemotherapy first beginsadds accurate information about patients responses to first-line chemotherapy, according to a study in the October issue of the Journal of Nuclear Medicine.

In our study, we demonstrated that a quantitative assessment of therapeutic response for patients with diffuse large B-cell lymphoma (DLBCL) is more accurate than visual analysis alone when using the radiotracer FDG (fluorodeoxyglucose) with PET scans, said Michel Meignan, professor of nuclear medicine at Henri Mondor Hospital in Creteil, France. The ability to predict tumor response early in the course of treatment is very valuable clinically, allowing intensification of treatment in those patients who are unlikely to response to first-line chemotherapy, he added. Similarly, treatment could possibly be shortened in those patients who show a favorable response after one or two cycles of chemotherapy, and quantification also may help identify the diseases transformation from low-grade to aggressive stage, he explained. However, visual interpretation of PET scans will always be the first step of analysis and will prevail in case of difficulties to quantify images, added Meignan.

Diffuse large B-cell lymphoma is a fast-growing, aggressive form of non-Hodgkin lymphoma, a cancer of the bodys lymphatic system. Although there are more than 20 types of NHL, DLBCL is the most common type, making up about 30 percent of all lymphomas. In the United States, about 63,190 people are expected to be diagnosed with non-Hodgkin lymphoma in 2007, according to recent statistics.

Ninety-two patients with DLBCL were studied before and aft
'/>"/>

Contact: Maryann Verrillo
mverrillo@snm.org
703-652-6773
Society of Nuclear Medicine
Source:Eurekalert

Page: 1 2

Related biology news :

1. Imaging Lymph Nodes with Nanoparticles
2. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
3. Special Imaging Study Shows Failing Hearts Are Energy Starved
4. Duke engineers develop new 3-D cardiac imaging probe
5. Confocal imaging promises early detection of skin cancer
6. Newer imaging techniques may lead to over-treatment
7. Researchers use 3-D imaging system to unveil swimming behavior of microscopic plankton
8. Microscopic brain imaging in the palm of your hand
9. New imaging technology shown to detect pancreatic inflammation in type 1 diabetes
10. Purdues gold nanorods brighten future for medical imaging
11. PET imaging reveals the immune system at work
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... Orange, NJ. April 16, 2014. Kessler Foundation has ... $1.8 million from the Department of Defense Spinal ... is principal investigator for the randomized, double-blinded, controlled, ... improve bone and muscle strength after spinal cord ... Performance & Engineering Research at Kessler Foundation. Two ...
(Date:4/17/2014)... N.M. A credit-card-sized anthrax detection cartridge developed at ... business makes testing safer, easier, faster and cheaper. ... anthrax, is commonly found in soils all over the ... in both humans and animals. The bacteria can survive ... B. anthracis may occur through skin contact, ...
(Date:4/17/2014)... Kansas State University engineer has developed a patented ... improvised explosive devices. The same technique could help ... Steven M. and Kay L. Theede chair in ... engineering, and his research team have created a ... in car trunks. The distance detection method ...
Breaking Biology News(10 mins):Kessler Foundation awarded Department of Defense grant for spinal cord injury research 2Pocket-sized anthrax detector aids global agriculture 2Pocket-sized anthrax detector aids global agriculture 3Patented research remotely detects nitrogen-rich explosives 2
... cancer-preventing potential of berries, red wine, and other foods are ... current issue of Chemical & Engineering News (C&EN), ACS, weekly ... substances in those foods and turn their potential into reality. ... have tried for years to develop drugs that reduce the ...
... team of scientists from the University of Nevada, Reno, ... has returned from a two-week expedition to Guatemala,s tropical ... solutions to the algae blooms that have assailed the ... The lake,s water is contaminated with watershed runoff ...
... Researchers in the University of Alabama at Birmingham (UAB) departments ... grant from the National Heart, Lung, and Blood Institute (NHLBI) ... to the potentially harmful changes in red blood cells that ... The UAB study will focus on the mechanisms by which ...
Cached Biology News:American team of scientists help protect Guatemala's Lake Atitlan 2American team of scientists help protect Guatemala's Lake Atitlan 3NHLBI grants $1.47 million to study red blood cell transfusion storage times and bioactivity 2
(Date:1/15/2014)... NY (PRWEB) January 15, 2014 The Microcompetition ... a major disease. One of these latent viruses is the ... rheumatoid arthritis (RA). Rheumatoid arthritis (RA) is a chronic inflammatory ... theory, a study found that RA patients have high concentrations ...
(Date:1/15/2014)... 2014 TaiGen Biotechnology Company, Limited ("TaiGen") today announced ... a leading Russian pharmaceutical company, to develop and commercialize ... Federation , Turkey and ... a novel antibiotic for the treatment of bacterial infections ...
(Date:1/14/2014)... , Jan. 14, 2014 As pet owners drew up their ... of them wrote: "Take better care of my furry companion." Nowadays ... clothes and top-brand carrying cases to take the little canine or ... also feel compelled to buy some pricey toys at the pet ...
(Date:1/14/2014)... January 14, 2014 In recent years, ... and methods in product development and promotion has led ... This mistrust, fueled by concerns about the insidious impact ... reports of spectacular fines to the world’s biggest pharmas ...
Breaking Biology Technology:Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4New Year's Resolution: Give Pets the Gift of Top-Notch Health Care 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3
... /PRNewswire/ - Sirius Genomics, a developer of pharmacogenomic diagnostics, ... Directors at its recent Annual General Meeting. The six-member ... Dreismann, Mr. Jim Heppell, Mr. Amos Michelson, Dr. Bradley ... expertise in molecular diagnostics, commercialization and personalized medicine experience ...
... ... Industry Opportunities at Major Food Conference , ... Anaheim, Calif. (Vocus) June 7, 2009 -- The next generation ... provide nutritionally enhanced oil with the highest oleic content in soybeans under commercial development. ...
... Therapeutics, Inc. (Nasdaq: OREX ), a biopharmaceutical company ... findings from the first of four Phase 3 trials of ... These data were presented in one oral and two ... Sessions in New Orleans, Louisiana. , , The ...
Cached Biology Technology:Sirius Genomics Announces 2009 Board of Directors 2Plenish™ High Oleic Soybean Oil Offers Trans Fat Solution with Superior Performance 2Plenish™ High Oleic Soybean Oil Offers Trans Fat Solution with Superior Performance 3Orexigen(R) Therapeutics Presents Additional NB-302 Contrave(R) Data at American Diabetes Association (ADA) 69th Scientific Sessions 2Orexigen(R) Therapeutics Presents Additional NB-302 Contrave(R) Data at American Diabetes Association (ADA) 69th Scientific Sessions 3Orexigen(R) Therapeutics Presents Additional NB-302 Contrave(R) Data at American Diabetes Association (ADA) 69th Scientific Sessions 4Orexigen(R) Therapeutics Presents Additional NB-302 Contrave(R) Data at American Diabetes Association (ADA) 69th Scientific Sessions 5